EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Relationship Between Hypothyroidism, Risk of Small Intestinal Bacterial Overgrowth, and Duodenal Microbiome Alterations

Margaret Wei, Sepideh Mehravar, Gabriela Leite, Parnian Naji, Gillian M Barlow iD, Ava Hosseini, Mohamad Rashid, Maritza Sanchez, Cristina M Fajardo, Mark Pimentel iD, Ruchi Mathur iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Margaret Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai, Los Angeles, CA 90048, USA. Hauptthemen laut MEDLINE: Hypothyroidism, Gastrointestinal Microbiome, Intestine, Small, Duodenum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

There is an association between hypothyroidism and small intestinal bacterial overgrowth (SIBO), but the exact mechanistic link between these 2 conditions is not fully elucidated.

Objective

We evaluate the incidence and risks of subsequently developing SIBO, and changes in small bowel microbial populations, in subjects with hypothyroidism or autoimmune thyroiditis. Design and Outcome Measures Duodenal aspirates from REIMAGINE study subjects with a history of hypothyroidism (hypothyroid group, N = 49) and controls (N = 323) underwent 16S rRNA sequencing (MiSeq, Illumina); a subset also underwent metagenomic sequencing (NovaSeq6000, Illumina). Separately, the TriNetX Analytics platform was used to evaluate 10-year cumulative incidences and relative risk (RR) of developing SIBO in subjects with hypothyroidism (unspecified etiology [HUE]), and a subset with autoimmune thyroiditis, vs propensity score matched control groups.

Results

Among REIMAGINE subjects, SIBO prevalence was higher in the hypothyroid group (32.65%) vs controls (15.17%). In the TriNetX analysis, 10-year cumulative incidences of SIBO were higher in HUE (RR = 2.20) and autoimmune thyroiditis (RR = 2.40) subjects vs matched controls. However, these risks appeared to be mitigated both in HUE (RR = 0.33) and autoimmune thyroiditis (RR = 0.78) subjects taking levothyroxine. Analyzing the duodenal microbiome, genus Neisseria was part of the core microbiome in the hypothyroid group (Hypo+/SIBO−, Hypo+/SIBO+) but not in nonhypothyroid subjects (Hypo−/SIBO−, Hypo−/SIBO+). Increased prevalence of Gram-negative coliforms occurred in both SIBO+ groups, but Escherichia/Shigella formed part of the core in nonhypothyroid subjects (Hypo−/SIBO+), whereas Klebsiella species were prevalent in hypothyroid group subjects with SIBO (Hypo+/SIBO+).

Conclusion

These findings suggest there is an increased risk for development of SIBO in individuals with a history of hypothyroidism that may be ameliorated by treatment, and may involve specific Gram-negative coliforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypothyroidismGastrointestinal MicrobiomeIntestine, SmallDuodenumBlind Loop SyndromeHumansMaleFemaleMiddle AgedAdultIncidenceCase-Control StudiesThyroiditis, AutoimmuneRisk FactorsRNA, Ribosomal, 16SAgedPrevalenceBacteria

Stichwörter der Autor:innen

Escherichia/ShigellaKlebsiellaautoimmune thyroiditishypothyroidismsmall intestinal bacterial overgrowthsmall intestinal microbiome

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai, Los Angeles, CA 90048, USA.
  • Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, West Hollywood, CA 90069, USA.
  • Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
  • Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai, Los Angeles, CA 90048, USA.

ORCID-Profile: Gillian M Barlow, Mark Pimentel, Ruchi Mathur

Zitieren

APA

Wei, M., Mehravar, S., Leite, G., Naji, P., Barlow, G. M., Hosseini, A., Rashid, M., Sanchez, M., Fajardo, C. M., Pimentel, M., & Mathur, R. (2026). Relationship Between Hypothyroidism, Risk of Small Intestinal Bacterial Overgrowth, and Duodenal Microbiome Alterations. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf495

Vancouver

Wei M, Mehravar S, Leite G, Naji P, Barlow GM, Hosseini A, et al. Relationship Between Hypothyroidism, Risk of Small Intestinal Bacterial Overgrowth, and Duodenal Microbiome Alterations. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf495

BibTeX
@article{Wei2026,
  author = {Wei, Margaret and Mehravar, Sepideh and Leite, Gabriela and Naji, Parnian and Barlow, Gillian M and Hosseini, Ava and Rashid, Mohamad and Sanchez, Maritza and Fajardo, Cristina M and Pimentel, Mark and Mathur, Ruchi},
  title = {Relationship Between Hypothyroidism, Risk of Small Intestinal Bacterial Overgrowth, and Duodenal Microbiome Alterations},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf495}
}
Kostenlos starten →